Rafferty Asset Management, LLC Geron Corp Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Geron Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 1,424,004 shares of GERN stock, worth $4.29 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,424,004

Previous 967,446 47.19%

Holding current value

$4.29 Million

Previous $4.1 Million 57.62%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.17 - $4.99 $1.9 Million - $2.28 Million	456,558 Added 47.19%	1,424,004 $6.46 Million
Q2 2024 Aug 13, 2024	SELL	$3.1 - $5.09 $4.48 Million - $7.35 Million	-1,443,765 Reduced 59.88%	967,446 $4.1 Million
Q1 2024 May 13, 2024	BUY	$1.75 - $3.44 $1.3 Million - $2.55 Million	742,124 Added 44.46%	2,411,211 $7.96 Million
Q4 2023 Feb 13, 2024	SELL	$1.74 - $2.31 $405,731 - $538,643	-233,179 Reduced 12.26%	1,669,087 $3.52 Million
Q3 2023 Nov 13, 2023	BUY	$2.11 - $3.28 $1.22 Million - $1.89 Million	577,422 Added 43.58%	1,902,266 $4.03 Million
Q2 2023 Aug 11, 2023	SELL	$1.97 - $3.69 $1.02 Million - $1.92 Million	-519,790 Reduced 28.18%	1,324,844 $4.25 Million
Q1 2023 May 11, 2023	BUY	$2.14 - $3.4 $1.21 Million - $1.92 Million	564,779 Added 44.13%	1,844,634 $4 Million
Q4 2022 Feb 13, 2023	BUY	$2.03 - $2.42 $1.48 Million - $1.76 Million	727,914 Added 131.88%	1,279,855 $3.1 Million
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $347,562 - $611,875	208,121 Added 60.53%	551,941 $1.29 Million
Q2 2022 Aug 12, 2022	SELL	$1.19 - $1.65 $342,495 - $474,888	-287,811 Reduced 45.57%	343,820 $533,000
Q1 2022 May 13, 2022	BUY	$0.99 - $1.6 $61,699 - $99,716	62,323 Added 10.95%	631,631 $859,000
Q4 2021 Feb 10, 2022	BUY	$1.22 - $1.72 $219,054 - $308,831	179,553 Added 46.07%	569,308 $695,000
Q3 2021 Nov 10, 2021	SELL	$1.2 - $1.5 $66,406 - $83,008	-55,339 Reduced 12.43%	389,755 $534,000
Q2 2021 Aug 10, 2021	SELL	$1.25 - $1.83 $410,750 - $601,338	-328,600 Reduced 42.47%	445,094 $628,000
Q1 2021 May 10, 2021	BUY	$1.52 - $2.1 $990,021 - $1.37 Million	651,330 Added 532.29%	773,694 $1.22 Million
Q4 2020 Feb 10, 2021	SELL	$1.55 - $2.05 $231,128 - $305,685	-149,115 Reduced 54.93%	122,364 $195,000
Q3 2020 Nov 13, 2020	BUY	$1.59 - $2.19 $431,651 - $594,539	271,479 New	271,479 $472,000

Others Institutions Holding GERN

# of Institutions

275

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.14B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Geron Corp Transaction History